Publication | Closed Access
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
249
Citations
13
References
2004
Year
OncologyGastrointestinal OncologyMedicinePharmacokinetic StudyPeg ImmunoliposomeTumor TargetingAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyMetastatic Stomach Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1